Risk of sexual transmission of HIV in the context of viral load suppression.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada
Published Date:

Abstract

BACKGROUND: In 2018, the Public Health Agency of Canada (PHAC) published a systematic review to calculate the risk of sexual transmission of human immunodeficiency virus (HIV) in the context of antiretroviral therapy (ART). In 2022, PHAC commissioned the Canadian Agency for Drugs and Technologies in Health (CADTH) to conduct a rapid review of evidence published since 2017. We undertook a meta-analysis of relevant studies from these two reviews.

Authors

  • Pascal Djiadeu
    Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.
  • Housne Begum
    Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.
  • Stacy Sabourin
    Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.
  • Stephan Gadient
    Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.
  • Chris Archibald
    Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.
  • Marc-AndrĂ© LeBlanc
    Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.
  • Andrea Chittle
    Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.
  • Annie Fleurant
    Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.
  • Joseph Cox
    Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, ON.

Keywords

No keywords available for this article.